Приказ основних података о документу
Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study
dc.creator | Doneva, Miglena | |
dc.creator | Milushewa, Petya | |
dc.creator | Dimitrova, Maria | |
dc.creator | Kamusheva, Maria | |
dc.creator | Stoitchkov, Jordan | |
dc.creator | Petrova, Guenka | |
dc.creator | Naydenova, Kremena | |
dc.creator | Krusheva, Borislava | |
dc.creator | Dimitrov, Vasil | |
dc.creator | Lakić, Dragana | |
dc.date.accessioned | 2022-07-27T10:36:55Z | |
dc.date.available | 2022-07-27T10:36:55Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 1310-2818 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/4202 | |
dc.description.abstract | This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease. | |
dc.publisher | Taylor and Francis Ltd. | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Biotechnology and Biotechnological Equipment | |
dc.subject | Asthma control | |
dc.subject | quality of life of patients | |
dc.subject | satisfaction of treatment | |
dc.title | Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study | |
dc.type | article | |
dc.rights.license | BY | |
dc.citation.volume | 36 | |
dc.citation.issue | 1 | |
dc.citation.spage | 478 | |
dc.citation.epage | 485 | |
dc.citation.rank | M23 | |
dc.identifier.wos | 000827990700001 | |
dc.identifier.doi | 10.1080/13102818.2022.2098818 | |
dc.identifier.scopus | 2-s2.0-85134371309 | |
dc.identifier.fulltext | http://farfar.pharmacy.bg.ac.rs/bitstream/id/10185/Quality_of_life_pub_2022.pdf | |
dc.type.version | publishedVersion |